WACKER CHEMIE AG |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 101.8 EUR | -0.78% |
|
+0.84% | -10.82% |
| 05/06 | Collective bargaining partners in the chemical industry adjourn again | DP |
| 31/05 | Wacker Chemie AG completed the acquisition of Assets of Bio Med Sciences Inc. | CI |
| Sales 2024 * | 6.14B 6.68B 557B | Sales 2025 * | 6.6B 7.19B 600B | Capitalization | 5.02B 5.46B 456B |
|---|---|---|---|---|---|
| Net income 2024 * | 225M 245M 20.44B | Net income 2025 * | 413M 450M 37.51B | EV / Sales 2024 * | 0.86 x |
| Net Debt 2024 * | 251M 274M 22.83B | Net Debt 2025 * | 197M 215M 17.89B | EV / Sales 2025 * | 0.79 x |
| P/E ratio 2024 * |
22.6
x | P/E ratio 2025 * |
12.5
x | Employees | 16,425 |
| Yield 2024 * |
2.44% | Yield 2025 * |
4.02% | Free-Float | 31.67% |
More Fundamentals
* Assessed data
More news
Latest transcript on Wacker Chemie AG
More recommendations
More press releases
More news
| 1 day | -0.78% | ||
| 1 week | +0.84% | ||
| 1 month | -0.78% | ||
| 3 months | +0.64% | ||
| 6 months | -8.62% | ||
| Current year | -10.82% |
1 week
99.02
103.10
1 month
97.66105.85
Current year
92.26116.10
1 year
92.26141.55
3 years
92.26184.55
5 years
32.75184.55
10 years
32.75184.55
| Managers | Title | Age | Since |
|---|---|---|---|
Christian Hartel
CEO | Chief Executive Officer | 53 | 01/15/01 |
Jörg Hoffmann
IRC | Investor Relations Contact | - | - |
Thomas Renner
PRN | Corporate Officer/Principal | - | 01/13/01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 08/08/08 | |
Matthias Biebl
BRD | Director/Board Member | 58 | 08/08/08 |
Susanne Weiss
BRD | Director/Board Member | 63 | 08/08/08 |
| Date | Price | Change |
|---|---|---|
| 05/24/05 | 101 | +0.05% |
| 04/24/04 | 101 | +0.80% |
| 03/24/03 | 100.2 | -1.57% |
| 31/24/31 | 101.8 | -0.78% |
| 30/24/30 | 102.6 | +1.64% |
End-of-day quote Wiener Boerse, May 31, 2024
More quotes
Wacker Chemie AG is a Germany-based manufacturer of specialty chemical products. It operates through four segments: Silicones, Polymers, Biosolutions and Polysilicon. The Silicones segments provides silane, silicone fluids, emulsions, elastomers, sealants and resins to pyrogenic silicas; the Polymers segment offers a range of polymeric binders and additives along with customized services; the Biosolutions segment serves the food, pharmaceutical, life science and agrochemical industries and produces fermenter cysteine and bioengineered cyclodextrins, among others, and the Polysilicon segment manufactures high-purity polysilicon for the solar technology and semiconductor-electronics industries.
Sector
Specialty Chemicals
Calendar
26/07/2024
- Q2 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
101
EUR
Average target price
127
EUR
Spread / Average Target
+25.74%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -2.43% | 19.8B | |
| +2.13% | 4.16B | |
| +13.23% | 1.54B | |
| -2.65% | 1.26B | |
| +16.44% | 943M | |
| -17.41% | 658M | |
| -38.91% | 550M | |
| -22.36% | 274M | |
| -6.04% | 252M |
- Stock Market
- Equities
- WCH Stock
- WCH Stock
